CLCD, a provider of children’s literature database products for educators and librarians in the United States, is releasing CLCD Enterprise Version 7.0, a milestone achievement that aims to transform ...

CoLucid Pharmaceuticals, Inc. CLCD was a big mover last session, as the company saw its shares rise roughly 10% on the day. The move came on solid volume too with far more shares changing hands than ...

CoLucid Pharmaceuticals, Inc. CLCD has been struggling lately, but the selling pressure may be coming to an end soon. That is because CLCD recently saw a Hammer Chart Pattern which can signal that the ...

Eli Lilly and Co (NYSE:LLY) just announced that it is set to acquire junior biotech CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) in a deal worth up to $960 million. The transaction is a pretty ...

Find the latest (CLCD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Towards the end of August, we published this piece detailing two major potential upside catalysts to keep an eye on early September. One of the companies we profiled was CoLucid Pharmaceuticals Inc ...

CAMBRIDGE, Mass., Dec. 8, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (Nasdaq:CLCD), a Phase 3 clinical-stage biopharmaceutical company that is developing its lead product candidate, ...

CoLucid Pharmaceuticals, Inc. CLCD has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because CLCD is now in overbought territory with an RSI ...

A brief overview of the NASDAQ:CLCD financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance ...

Find the latest (CLCD) stock quote, history, news and other vital information to help you with your stock trading and investing.